Dakos Andrew, President and CEO, has filed 56 Form 4 transactions across three companies. The pattern is heavily weighted toward buying. His open-market purchases total $953,697.08, against open-market sales of $236,478.21. He also received $91,686.17 in grants, which are compensation and not purchases. The recent activity, from April through September 2026, shows 19 purchase codes versus 4 sale codes.
The buying is concentrated in SWZ. Between April 7 and September 28, 2026, Andrew filed 19 open-market purchases in that ticker. The individual amounts range from $77.35 on May 19 to $51,930 on September 28. Many of the purchases cluster on single days, such as three separate filings on April 16 totaling $50,044.96, and two on September 28 totaling $57,690. He also made two purchases in May, two in July, and one in September. The only sales in this period were in SPE, with four filings on June 2 and June 3 totaling $95,117.09.
The most recent filings are not purchases. On October 20, 2026, Andrew received a grant of TRC stock valued at $16,560.62. That followed a July 14 TRC grant of $17,166.60. The last open-market purchase was the September 28 SWZ buy. The transaction pattern shows a clear bias toward accumulating SWZ shares through the spring and summer, with the SPE sales in early June as the only significant disposal.
AI-assisted summary